A positive feedback regulation of ISL-1 in DLBCL but not in pancreatic β-cells.

Qiao Zhang, Zhe Yang, Weiping Wang, Ting Guo, Zhuqing Jia, Kangtao Ma, Chunyan Zhou

Biochemical and biophysical research communications 2014 Jul 4

filter terms:

Insulin enhancer binding protein-1 (ISL-1), a LIM-homeodomain transcription factor, has been reported to play essential roles in promoting adult pancreatic β-cells proliferation. Recent studies indicate that ISL-1 may also involve in the occurrence of a variety of tumors. However, whether ISL-1 has any functional effect on tumorigenesis, and what are the differences on ISL-1 function in distinct conditions, are completely unknown. In this study, we found that ISL-1 was highly expressed in human pancreatic β-cells, as well as in diffuse large B cell lymphoma (DLBCL), but to a much less extent in other normal tissues or tumor specimens. Further study revealed that ISL-1 promoted the proliferation of pancreatic β-cells and DLBCL cells, and also accelerated the tumorigenesis of DLBCL in vivo. We also found that ISL-1 could activate c-Myc transcription not only in pancreatic β-cells but also in DLBCL cells. However, a cell-specific feedback regulation was detectable only in DLBCL cells. This auto-regulatory loop was established by the interaction of ISL-1 and c-Myc to form an ISL-1/c-Myc transcriptional complex, and synergistically to promote ISL-1 transcription through binding on the ISL-1 promoter. Taken together, our results demonstrate a positive feedback regulation of ISL-1 in DLBCL but not in pancreatic β-cells, which might result in the functional diversities of ISL-1 in different physiological and pathological processes. Copyright © 2014 Elsevier Inc. All rights reserved.

Citation

Qiao Zhang, Zhe Yang, Weiping Wang, Ting Guo, Zhuqing Jia, Kangtao Ma, Chunyan Zhou. A positive feedback regulation of ISL-1 in DLBCL but not in pancreatic β-cells. Biochemical and biophysical research communications. 2014 Jul 4;449(3):295-300